Huadong Medicine Co. Ltd. A | Ownership
Companies that own Huadong Medicine Co. Ltd. A
China Asset Management Co., Ltd.
47,600,620
3.66%
21,207,863
1.61%
06/30/2018
Harvest Fund Management Co., Ltd.
41,121,432
3.16%
22,840,998
1.87%
03/31/2018
Bosera Asset Management Co., Ltd.
18,223,890
1.4%
-900,000
0.98%
03/31/2018
Great Wall Fund Management Co., Ltd.
10,080,922
0.77%
-4,697,387
4.15%
12/31/2017
Taikang Asset Management Co., Ltd.
9,191,144
0.71%
-2,411,974
1.43%
03/31/2018
New China Asset Management Co., Ltd.
8,482,590
0.65%
215,100
3.26%
03/31/2018
Monetary Authority of Macao (Investment Management)
8,250,827
0.63%
8,250,827
11%
03/31/2018
Green Court Capital Management Ltd.
7,081,470
0.54%
250,213
2.82%
03/31/2018
Schroder Investment Management (Hong Kong) Ltd.
5,899,027
0.45%
4,423,303
0.2%
05/31/2018
Essence Fund Co., Ltd.
5,696,735
0.44%
2,116,304
1.66%
12/31/2017
| Address |
No. 866 Moganshan Road
Hangzhou Zhejiang 310011
China
|
|
Employees
|
- |
| Website |
http://www.eastchinapharm.com |
| Updated |
07/08/2019 |
| Huadong Medicine Co., Ltd. engages in the production and sale of antibiotics, proprietary Chinese medicine, chemical synthetic medicine, and genetic engineering drugs. It involves in wholesale, retail, and distribution of Chinese and western medicine, Chinese herbal medicine, medical apparatus and instruments. Its products include Chinese medicine, drug immune agents, endocrine drugs, gastrointestinal agents, active pharmaceutical ingredient, hepatitis B medicine, and antineoplastic agents. |
